According to Aptose Biosciences's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -1.59 | -77.13% |
2023-12-31 | -6.96 | -544.41% |
2022-12-31 | 1.57 | -3.61% |
2021-12-31 | 1.63 | -50.38% |
2020-12-31 | 3.28 | -28.13% |
2019-12-31 | 4.56 | -11.87% |
2018-12-31 | 5.17 | -11.79% |
2017-12-31 | 5.87 | 137.94% |
2016-12-31 | 2.47 | 7.67% |
2015-12-31 | 2.29 | -5.39% |
2014-12-31 | 2.42 | -114.44% |
2013-12-31 | -16.8 | -309.2% |
2012-12-31 | 8.01 | -113.04% |
2011-12-31 | -61.4 | -639.17% |
2010-12-31 | 11.4 | 40.21% |
2009-12-31 | 8.12 | -476.84% |
2008-12-31 | -2.16 | -115.33% |
2007-12-31 | 14.1 | 6.49% |
2006-12-31 | 13.2 | -7.81% |
2005-12-31 | 14.3 | 121.23% |
2004-12-31 | 6.47 | 70.57% |
2003-12-31 | 3.79 | 84.37% |
2002-12-31 | 2.06 |